Introduction Biologics have revolutionized the therapy of moderate-to-severe plaque
psoriasis. Despite their greater efficacy over conventional systemic therapies their high cost …

Background Total work productivity loss (WPL) and associated indirect costs contribute to
the economic burden of psoriasis. Objectives To estimate total WPL and related indirect …

Introduction The clinical benefits of biologic and oral treatments for moderate-to-severe
plaque psoriasis are well-established, but efficacy outcomes can vary across therapies …

Background Psoriasis imposes a substantial burden on patients' social, emotional, physical,
and family life. Although psoriasis has no complete cure, various treatments are available to …

Psoriasis poses a substantial economic burden by reducing the work productivity of affected
patients. We aimed to evaluate the negative impact of plaque psoriasis on work productivity …

Background Optical coherence tomography (OCT) is a noninvasive imaging device that
scans the skin up to 2 mm in depth. OCT can capture real‐time epidermal thickness (ET) …

Importance The ability to predict the efficacy of systemic psoriasis therapy based on immune
profiles in skin biopsies could reduce the use of inappropriate treatment and its associated …

Background: Psoriasis is a chronic disease that derives great costs to the health care
system. In Colombia, due to deficiencies in this system, patients are more likely to incur in …

Background: Psoriasis is a long lasting immune-mediated disease that has a significant
ferocious effect on quality of life (QOL). It is often accompanied with social stigmatization …

Background: Little is known about the extent of impairments in work and activities of daily life
(ADL) in patients with psoriasis, and the influence of contextual factors such as disease …